Literature DB >> 2869211

Plasma fibronectin deficiency in eight members of one family.

A Shirakami, T Shigekiyo, Y Hirai, T Takeichi, S Kawauchi, S Saito, K Miyoshi.   

Abstract

The proband, a 31-year-old female, had keloids at the sites of surgery and burns. Her plasma fibronectin level measured by Laurell's method was only 10 mg/dl (mean +/- SD in 101 healthy controls 32.2 +/- 5.6 mg/dl) but the electrophoretic mobility was normal. Low levels of plasma fibronectin (range 11-17 mg/dl) were found in the proband's mother, two uncles, two brothers, one daughter, and one nephew. Levels in her father and other family members examined were normal (range 32-51 mg/dl). The proband has been quite healthy, an haematological and haemostatic tests showed no abnormality except reduced phagocytosis by neutrophils. Other family members with low plasma fibronectin levels had no abnormalities on examination and no keloids.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2869211     DOI: 10.1016/s0140-6736(86)92931-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

1.  Enhancement of thrombogenesis by plasma fibronectin cross-linked to fibrin and assembled in platelet thrombi.

Authors:  Jaehyung Cho; Deane F Mosher
Journal:  Blood       Date:  2006-01-03       Impact factor: 22.113

2.  Fibronectin degradation products containing the cytoadhesive tetrapeptide stimulate human neutrophil degranulation.

Authors:  Y T Wachtfogel; W Abrams; U Kucich; G Weinbaum; M Schapira; R W Colman
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

3.  Plasma fibronectin supports hemostasis and regulates thrombosis.

Authors:  Yiming Wang; Adili Reheman; Christopher M Spring; Jalil Kalantari; Alexandra H Marshall; Alisa S Wolberg; Peter L Gross; Jeffrey I Weitz; Margaret L Rand; Deane F Mosher; John Freedman; Heyu Ni
Journal:  J Clin Invest       Date:  2014-09-02       Impact factor: 14.808

Review 4.  Emerging roles of fibronectin in thrombosis.

Authors:  Lisa M Maurer; Bianca R Tomasini-Johansson; Deane F Mosher
Journal:  Thromb Res       Date:  2010-02-08       Impact factor: 3.944

5.  PEGylated pUR4/FUD peptide inhibitor of fibronectin fibrillogenesis decreases fibrosis in murine Unilateral Ureteral Obstruction model of kidney disease.

Authors:  Bianca R Tomasini-Johansson; Pawel W Zbyszynski; Inger Toraason; Donna M Peters; Glen S Kwon
Journal:  PLoS One       Date:  2018-10-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.